BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32409929)

  • 1. Does lymph node ratio have any prognostic significance in maximally cytoreduced node-positive low-grade serous ovarian carcinoma?
    Aslan K; Meydanli MM; Akilli H; Durmuş Y; Gökçü M; Kayıkçıoğlu F; Demirkiran F; Ayhan A
    Arch Gynecol Obstet; 2020 Jul; 302(1):183-190. PubMed ID: 32409929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.
    Ayhan A; Ozkan NT; Sarı ME; Celik H; Dede M; Akbayır Ö; Güngördük K; Şahin H; Haberal A; Güngör T; Arvas M; Meydanlı MM
    J Gynecol Oncol; 2018 Jan; 29(1):e12. PubMed ID: 29185270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
    Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
    J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
    Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
    Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of lymph node ratio on survival of women with borderline ovarian tumors.
    Nusbaum DJ; Mandelbaum RS; Machida H; Matsuzaki S; Roman LD; Sood AK; Gershenson DM; Matsuo K
    Arch Gynecol Obstet; 2020 May; 301(5):1289-1298. PubMed ID: 32303888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy.
    Cuylan ZF; Meydanli MM; Sari ME; Akbayir O; Celik H; Dede M; Sahin H; Gungorduk K; Kuscu E; Ozgul N; Gungor T; Ayhan A
    J Obstet Gynaecol Res; 2018 Jul; 44(7):1284-1293. PubMed ID: 29727055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.
    Matsuo K; Wong KK; Fotopoulou C; Blake EA; Robertson SE; Pejovic T; Frimer M; Pardeshi V; Hu W; Choi JS; Sun CC; Richmond AM; Marcus JZ; Hilliard MAM; Mostofizadeh S; Mhawech-Fauceglia P; Abdulfatah E; Post MD; Saglam O; Shahzad MMK; Karabakhtsian RG; Ali-Fehmi R; Gabra H; Roman LD; Sood AK; Gershenson DM
    J Surg Oncol; 2018 Feb; 117(2):236-244. PubMed ID: 28787528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?
    Yamagata K; Fukuzawa S; Kanno N; Uchida F; Yanagawa T; Bukawa H
    J Oral Maxillofac Surg; 2019 Jul; 77(7):1510-1519. PubMed ID: 30822404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
    De la Cruz-Ku GA; Chambergo-Michilot D; Valcarcel B; Rebaza P; Möller M; Araujo JM; Enriquez D; Morante Z; Razuri C; Luque R; Saavedra A; Eyzaguirre E; Lujan M; Noel N; Pinto J; Cotrina J; Gomez H
    Breast J; 2020 Sep; 26(9):1659-1666. PubMed ID: 32713113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.
    Ayhan A; Topfedaisi Ozkan N; Öz M; Kimyon Comert G; Firat Cuylan Z; Çoban G; Turkmen O; Erdem B; Şahin H; Akbayır Ö; Dede M; Turan AT; Celik H; Güngör T; Haberal A; Arvas M; Meydanli MM
    J Gynecol Oncol; 2018 Jul; 29(4):e48. PubMed ID: 29770619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of regional positive lymph node ratio of gallbladder carcinoma on prognosis].
    Zhou YM; Mi HC; Jiang W; Jiang Y; Hua YF; Lu CJ; Wang CN; Lu CD
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1202-1207. PubMed ID: 36380669
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
    Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
    Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Lymph Node Ratio in Patients with Resected Synchronous Colorectal Liver Metastases and Less Than 12 Examined Lymph Nodes.
    Alexandrescu ST; Selaru FM; Diaconescu AS; Zlate CA; Blanita D; Grigorie RT; Zarnescu NO; Herlea V; Popescu I
    J Gastrointest Surg; 2022 Jan; 26(1):141-149. PubMed ID: 34258674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on the effects of neoadjuvant chemotherapy on lymph node ratio, prognosis, and survival analysis of stage ⅢA-N2 non-small cell lung cancer].
    Wei YL; Cui YH; Dong YH; Shi WJ
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):259-264. PubMed ID: 33486934
    [No Abstract]   [Full Text] [Related]  

  • 17. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.
    Li X; Lin H; Sun Y; Gong J; Feng H; Tu J
    J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
    Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A
    Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.
    Wang J; Liu F; Ma W; Hu H; Li F
    Langenbecks Arch Surg; 2023 Sep; 408(1):382. PubMed ID: 37770780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.